All Stories

  1. Potential Role of Bioactive Lipids in Rheumatoid Arthritis
  2. Clinical and Nutritional Implications of Kidney Disease and COVID-19
  3. Phytotherapy for Cardiovascular Disease: A Bench-to-Bedside Approach
  4. Is “Leptin Resistance” Another Key Resistance to Manage Type 2 Diabetes?
  5. Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
  6. Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association
  7. Cigarette smoking and metabolic syndrome components: a cross-sectional study from Maracaibo City, Venezuela
  8. Cigarette smoking and metabolic syndrome components: a cross-sectional study from Maracaibo City, Venezuela
  9. Non-HDL cholesterol is better than LDL-c at predicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a Venezuelan population
  10. Insulin resistance indices and coronary risk in adults from Maracaibo city, Venezuela: A cross sectional study
  11. Biochemical and clinical characterization of metabolic phenotypes: a cross-sectional study from Maracaibo city, Venezuela
  12. Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy
  13. Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population
  14. Insulin resistance indices and coronary risk in adults from Maracaibo city, Venezuela: A cross sectional study
  15. Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism
  16. Dysglycemic states and hypertension: A relationship dependent on low-grade inflammation
  17. Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population
  18. Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population
  19. 0000-0003-1880-8887
  20. Smoking Habit in Adult Population from Maracaibo City, Venezuela
  21. Comentario al artículo “Volumen de grasa visceral como indicador de obesidad en hombres adultos”
  22. Diabetes and Impaired Fasting Glucose Prediction Using Anthropometric Indices in Adults from Maracaibo City, Venezuela
  23. Factores de riesgo para hipertensión arterial en población adulta de una región urbana de Ecuador
  24. Punto de corte de circunferencia abdominal para el agrupamiento de factores de riesgo metabólico: una propuesta para la población adulta de Cuenca, Ecuador
  25. Epicardial Fat: Physiological, Pathological, and Therapeutic Implications
  26. Prevalence and Associated Factors of Insulin Resistance in Adults from Maracaibo City, Venezuela
  27. Prevalence and Risk Factors associated with Impaired Fasting Glucose in Adults from Maracaibo City, Venezuela
  28. Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics
  29. Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis
  30. Physiologic Course of female reproductive function
  31. Relationship between Alcohol Consumption and Components of the Metabolic Syndrome in Adult Population from Maracaibo City, Venezuela
  32. Sensitivity and Specificity Improvement in Abdominal Obesity Diagnosis Using Cluster Analysis during Waist Circumference Cut-Off Point Selection
  33. Peripheral and Autonomic Neuropathy in an Adolescent with Type 1 Diabetes Mellitus: Evidence of Symptom Reversibility after Successful Correction of Hyperglycemia
  34. Foliculitis queloidea: a propósito de un caso
  35. Obesidad y Síndrome de Ovario Poliquístico, una Condición No “Sine Qua Non”, a Propósito de un Caso Clínico
  36. OBESITY AND POLYCYSTIC OVARY SYNDROME, A CONDITION NO “SINE QUA NON”, APROPOS
  37. The Role of Adiponectin in Endothelial Dysfunction and Hypertension
  38. C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation
  39. C-Reactive Protein: Clinical and Epidemiological Perspectives
  40. Epidemiologic Behavior and Estimation of an Optimal Cut-Off Point for Homeostasis Model Assessment-2 Insulin Resistance: A Report from a Venezuelan Population
  41. Glucosamine for Osteoarthritis: Biological Effects, Clinical Efficacy, and Safety on Glucose Metabolism
  42. Optimal Waist Circumference Cut-Off Point for Multiple Risk Factor Aggregation: Results from the Maracaibo City Metabolic Syndrome Prevalence Study
  43. Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
  44. Successful Management of Insulin Allergy and Autoimmune Polyendocrine Syndrome Type 4 with Desensitization Therapy and Glucocorticoid Treatment: A Case Report and Review of the Literature
  45. The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus
  46. Polimorfismo 3’UTR +62G>A del gen RETN codificante de resistina y asociación con componentes del síndrome metabólico
  47. Approach to a Successful Selection of Antihypertensive Drugs for the Patient With Atherosclerosis
  48. International Physical Activity Questionnaire Overestimation is Ameliorated by Individual Analysis of the Scores
  49. Introductory Remarks for the First Interamerican Congress of Diabetes Maracaibo-Venezuela, July 2010
  50. Obesity Genetics
  51. Single-Nucleotide Polymorphisms in Adiponectin, AdipoR1, and AdipoR2 Genes
  52. Variations of Lipoprotein(a) Levels in the Metabolic Syndrome: A Report from the Maracaibo City Metabolic Syndrome Prevalence Study
  53. Targeting Hypertension in Patients with Cardiorenal Metabolic Syndrome
  54. Epidemiologic Behavior of Obesity in the Maracaibo City Metabolic Syndrome Prevalence Study
  55. Evidence of zoonotic Chlamydophila psittaci transmission in a population at risk in Zulia state, Venezuela
  56. The Sick Adipocyte Theory: The Forces of Clustering at Glance
  57. AMPK as Target for Intervention in Childhood and Adolescent Obesity
  58. Introductory Remarks
  59. Direct Renin Inhibitors as Antihypertensive Agents
  60. PPAR-γ Agonists and Their Role in Type 2 Diabetes Mellitus Management
  61. An Elevated Level of Physical Activity Is Associated With Normal Lipoprotein(a) Levels in Individuals From Maracaibo, Venezuela
  62. Association Between Apoliprotein E Gene Polymorphism and Hypercholesterolemic Phenotype in Maracaibo, Zulia State, Venezuela
  63. Determination of Non-HDL Cholesterol in Diabetic and Hypertensive Patients
  64. Effects of Metoclopramide and Metoclopramide/Dopamine on Blood Pressure and Insulin Release in Normotensive, Hypertensive, and Type 2 Diabetic Subjects
  65. Haemodynamical Variables Versus Endothelial Hormones in Hypertensive and Type 2 Diabetic Patients With Endothelial Dysfunction
  66. Latent Autoimmune Diabetes in Adults: A Case Report
  67. Lipoprotein(a): From Molecules to Therapeutics
  68. Novel Mutations Identification in Exon 4 of LDLR Gene in Patients With Moderate Hypercholesterolemia in a Venezuelan Population
  69. The Maracaibo City Metabolic Syndrome Prevalence Study: Design and Scope
  70. Infección por Chlamydia trachomatis en mujeres consultantes en Maracaibo, Venezuela
  71. Detección de Mycoplasma genitalium y correlación con manifestaciones clínicas en una población del estado Zulia, Venezuela
  72. Homeostasis Model Assessment (HOMA) as Surrogate Insulinization Criteria in Patients With Type 2 Diabetes
  73. Molecular Mechanisms of Endothelial Dysfunction: From Nitric Oxide Synthesis to ADMA Inhibition
  74. Effect of Drugs Interacting With the Dopaminergic Receptors on Glucose Levels and Insulin Release in Healthy and Type 2 Diabetic Subjects
  75. Metabolic and Hemodynamic Markers of Endothelial Dysfunction in Patients With Hypertension and Patients With Type 2 Diabetes During the Cold Pressor Test
  76. Pharmacologic Management of Isolated Low High-Density Lipoprotein Syndrome
  77. Metformin Plus Low-Dose Glimeperide Significantly Improves Homeostasis Model Assessment for Insulin Resistance (HOMAIR) and ??-Cell Function (HOMA??-cell) Without Hyperinsulinemia in Patients With Type 2 Diabetes Mellitus
  78. Oat-derived ??-Glucan Significantly Improves HDLC and Diminishes LDLC and Non-HDL Cholesterol in Overweight Individuals With Mild Hypercholesterolemia
  79. Effect of Cigarette Smoking on the Oxidant/Antioxidant Balance in Healthy Subjects
  80. Ciprofibrate Treatment Decreases Non-high Density Lipoprotein Cholesterol and Triglycerides and Increases High Density Lipoprotein Cholesterol in Patients With Frederickson Type IV Dyslipidemia Phenotype
  81. Incremento de las concentraciones séricas de malondialdehído y glutatión reducido en pacientes con cardiopatía isquémica crónica estable
  82. Increased Serum Malondialdehyde and Decreased Nitric Oxide Within 24 Hours of Thrombotic Stroke Onset
  83. Sweeteners and Beta-Glucans Improve Metabolic and Anthropometrics Variables in Well Controlled Type 2 Diabetic Patients
  84. Trimetazidine Diminishes Fasting Glucose in Rats With Fasting Hyperglycemia: A Preliminary Study
  85. Comportamiento del malondialdehído y el óxido nítrico séricos en pacientes con infarto de miocardio